Detail akcie Braster online

Business Summary: Braster SA w restrukturyzacji, formerly Braster SA, is a Poland-based company principally engaged in the bio diagnostics and testing. The Company provides research and development on breast cancer. It applies liquid crystals and liquid crystal emulsion formula that is used to produce liquid crystal matrix based on LCD technology, continuous film CLCF (Continuous Liquid Crystal Film) in the diagnosis of breast cancer. Its main product is Braster Tester, which is a device that uses thermographic liquid crystal matrices for diagnosing breast cancer; the device is made up of three film matrices covered with a liquid crystal mixture that allows thermal imaging. The Company cooperates with the Jagiellonian University, with the participation of the clinical trial conducted by Thermacrac, among others.
Financial Summary: BRIEF: For the nine months ended 30 September 2023, Braster SA revenues decreased 82% to PLN205K. Net loss decreased 1% to PLN2.9M. Revenues reflect Sales of Products decrease from PLN1.1M to -PLN15K. Lower net loss reflects Selling Expenses decrease of 91% to PLN21K (expense), Operating Expense- Other decrease from PLN209K (expense) to PLN0K, Interest Expense decrease of 14% to PLN761K (expense).